US FDA News: FDA approves new treatment for osteoporosis in postmenopausal women at high risk of fracture

FDA approves a new treatment for osteoporosis in postmenopausal women at high risk of breaking a bone (fracture).
Read more: FDA approves new treatment for osteoporosis in postmenopausal women at high risk of fracture